A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis-Reference-Cited by-同舟云学术

A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis

Published:2018-10-11 Issue:1 Volume:16 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Rai Pradeep K.,Chodisetti Sathi Babu,Maurya Sudeep K.,Nadeem Sajid,Zeng Weiguang,Janmeja Ashok K.,Jackson David C.,Agrewala Javed N.

Funder

Department of Biotechnology, Ministry of Science and Technology

Council of Scientific and Industrial Research

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-018-1653-x.pdf

Reference54 articles.

1. Organization WH: Global tuberculosis report 2017. In: Global tuberculosis report 2017. 2017.

2. Gowthaman U, Rai PK, Khan N, Jackson DC, Agrewala JN. Lipidated promiscuous peptides vaccine for tuberculosis-endemic regions. Trends Mol Med. 2012;18:607–14.

3. Andersen P, Doherty TM. The success and failure of BCG—implications for a novel tuberculosis vaccine. Nat Rev Microbiol. 2005;3:656–62.

4. Andersen P. TB vaccines: progress and problems. Trends Immunol. 2001;22:160–8.

5. Dockrell HM, Smith SG. What have we learnt about BCG vaccination in the last 20 years? Front Immunol. 2017;8:1134.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel strategy to elicit enduring anti-morphine immunity and relief from addiction by targeting Acr1 protein nano vaccine through TLR-2 to dendritic cells;International Journal of Biological Macromolecules;2024-08

2. Helicobacter pylori induces urease subunit B‐specific CD8⁺ T cell responses in infected individuals via cytosolic pathway of cross‐presentation;Helicobacter;2023-06-29

3. Tuberculosis: The success tale of less explored dormant Mycobacterium tuberculosis;Frontiers in Cellular and Infection Microbiology;2022-12-22

4. Pam2CSK4-adjuvanted SARS-CoV-2 RBD nanoparticle vaccine induces robust humoral and cellular immune responses;Frontiers in Immunology;2022-12-09

5. Hydrogel-guided strategies to stimulate an effective immune response for vaccine-based cancer immunotherapy;Science Advances;2022-11-25